nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—embryo—testicular cancer	0.0729	0.174	CbGeAlD
Amifostine—ALPPL2—gonad—testicular cancer	0.0495	0.118	CbGeAlD
Amifostine—ALPL—female gonad—testicular cancer	0.0454	0.109	CbGeAlD
Amifostine—ENPP1—female gonad—testicular cancer	0.0417	0.0996	CbGeAlD
Amifostine—ALPL—testis—testicular cancer	0.0403	0.0962	CbGeAlD
Amifostine—ALPPL2—female gonad—testicular cancer	0.0402	0.096	CbGeAlD
Amifostine—ENPP1—testis—testicular cancer	0.037	0.0884	CbGeAlD
Amifostine—ALPPL2—testis—testicular cancer	0.0357	0.0852	CbGeAlD
Amifostine—ALPL—lymph node—testicular cancer	0.0292	0.0698	CbGeAlD
Amifostine—ENPP1—lymph node—testicular cancer	0.0268	0.064	CbGeAlD
Amifostine—Chest discomfort—Etoposide—testicular cancer	0.00623	0.0107	CcSEcCtD
Amifostine—Hiccups—Cisplatin—testicular cancer	0.00602	0.0104	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.00585	0.0101	CcSEcCtD
Amifostine—Body temperature increased—Carboplatin—testicular cancer	0.00578	0.00995	CcSEcCtD
Amifostine—Atrial fibrillation—Ifosfamide—testicular cancer	0.00535	0.0092	CcSEcCtD
Amifostine—Acute coronary syndrome—Vinblastine—testicular cancer	0.00533	0.00917	CcSEcCtD
Amifostine—Myocardial infarction—Vinblastine—testicular cancer	0.0053	0.00912	CcSEcCtD
Amifostine—Erythema multiforme—Chlorambucil—testicular cancer	0.00501	0.00862	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Dactinomycin—testicular cancer	0.00498	0.00856	CcSEcCtD
Amifostine—Cardiac arrest—Ifosfamide—testicular cancer	0.00482	0.00829	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Ifosfamide—testicular cancer	0.00456	0.00785	CcSEcCtD
Amifostine—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00451	0.00776	CcSEcCtD
Amifostine—Acute coronary syndrome—Bleomycin—testicular cancer	0.0045	0.00775	CcSEcCtD
Amifostine—Myocardial infarction—Bleomycin—testicular cancer	0.00448	0.0077	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00422	0.00727	CcSEcCtD
Amifostine—Anaphylactoid reaction—Etoposide—testicular cancer	0.00413	0.00711	CcSEcCtD
Amifostine—Convulsion—Chlorambucil—testicular cancer	0.004	0.00688	CcSEcCtD
Amifostine—Feeling hot—Epirubicin—testicular cancer	0.00394	0.00677	CcSEcCtD
Amifostine—Ill-defined disorder—Vinblastine—testicular cancer	0.00392	0.00675	CcSEcCtD
Amifostine—Apnoea—Methotrexate—testicular cancer	0.00389	0.0067	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00387	0.00666	CcSEcCtD
Amifostine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.00385	0.00662	CcSEcCtD
Amifostine—Renal failure—Ifosfamide—testicular cancer	0.00384	0.0066	CcSEcCtD
Amifostine—Myocardial infarction—Ifosfamide—testicular cancer	0.00383	0.00658	CcSEcCtD
Amifostine—Malaise—Vinblastine—testicular cancer	0.00381	0.00656	CcSEcCtD
Amifostine—Flushing—Bleomycin—testicular cancer	0.00381	0.00655	CcSEcCtD
Amifostine—Cardiac arrest—Etoposide—testicular cancer	0.0038	0.00655	CcSEcCtD
Amifostine—Rigors—Epirubicin—testicular cancer	0.00378	0.00651	CcSEcCtD
Amifostine—Chills—Bleomycin—testicular cancer	0.00368	0.00633	CcSEcCtD
Amifostine—Convulsion—Vinblastine—testicular cancer	0.00366	0.0063	CcSEcCtD
Amifostine—Hypertension—Vinblastine—testicular cancer	0.00365	0.00628	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—testicular cancer	0.00364	0.00627	CcSEcCtD
Amifostine—Erythema multiforme—Dactinomycin—testicular cancer	0.00362	0.00622	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.0036	0.0062	CcSEcCtD
Amifostine—Bradycardia—Ifosfamide—testicular cancer	0.00357	0.00614	CcSEcCtD
Amifostine—Discomfort—Vinblastine—testicular cancer	0.00355	0.00612	CcSEcCtD
Amifostine—Flushing—Dactinomycin—testicular cancer	0.00355	0.00611	CcSEcCtD
Amifostine—Rigors—Doxorubicin—testicular cancer	0.0035	0.00602	CcSEcCtD
Amifostine—Chills—Dactinomycin—testicular cancer	0.00343	0.0059	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—testicular cancer	0.00337	0.00581	CcSEcCtD
Amifostine—Acute coronary syndrome—Cisplatin—testicular cancer	0.00332	0.00571	CcSEcCtD
Amifostine—Erythema multiforme—Ifosfamide—testicular cancer	0.00331	0.0057	CcSEcCtD
Amifostine—Ill-defined disorder—Bleomycin—testicular cancer	0.00331	0.0057	CcSEcCtD
Amifostine—Renal failure—Cisplatin—testicular cancer	0.00331	0.00569	CcSEcCtD
Amifostine—Myocardial infarction—Cisplatin—testicular cancer	0.0033	0.00568	CcSEcCtD
Amifostine—Flushing—Ifosfamide—testicular cancer	0.00325	0.0056	CcSEcCtD
Amifostine—Malaise—Bleomycin—testicular cancer	0.00322	0.00554	CcSEcCtD
Amifostine—Chills—Ifosfamide—testicular cancer	0.00314	0.00541	CcSEcCtD
Amifostine—Arrhythmia—Ifosfamide—testicular cancer	0.00313	0.00539	CcSEcCtD
Amifostine—Hypocalcaemia—Doxorubicin—testicular cancer	0.00312	0.00537	CcSEcCtD
Amifostine—Feeling abnormal—Chlorambucil—testicular cancer	0.0031	0.00534	CcSEcCtD
Amifostine—Hiccups—Epirubicin—testicular cancer	0.00309	0.00532	CcSEcCtD
Amifostine—Ill-defined disorder—Dactinomycin—testicular cancer	0.00309	0.00531	CcSEcCtD
Amifostine—Bradycardia—Cisplatin—testicular cancer	0.00308	0.00529	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00306	0.00526	CcSEcCtD
Amifostine—Acute coronary syndrome—Etoposide—testicular cancer	0.00304	0.00523	CcSEcCtD
Amifostine—Chest pain—Bleomycin—testicular cancer	0.00304	0.00523	CcSEcCtD
Amifostine—Renal failure—Etoposide—testicular cancer	0.00303	0.00521	CcSEcCtD
Amifostine—Myocardial infarction—Etoposide—testicular cancer	0.00302	0.0052	CcSEcCtD
Amifostine—Discomfort—Bleomycin—testicular cancer	0.003	0.00517	CcSEcCtD
Amifostine—Malaise—Dactinomycin—testicular cancer	0.003	0.00517	CcSEcCtD
Amifostine—Urticaria—Chlorambucil—testicular cancer	0.00299	0.00514	CcSEcCtD
Amifostine—Body temperature increased—Chlorambucil—testicular cancer	0.00298	0.00512	CcSEcCtD
Amifostine—Anaphylactic shock—Bleomycin—testicular cancer	0.00291	0.00501	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—testicular cancer	0.00286	0.00492	CcSEcCtD
Amifostine—Feeling abnormal—Vinblastine—testicular cancer	0.00284	0.00489	CcSEcCtD
Amifostine—Ill-defined disorder—Ifosfamide—testicular cancer	0.00283	0.00487	CcSEcCtD
Amifostine—Flushing—Cisplatin—testicular cancer	0.0028	0.00482	CcSEcCtD
Amifostine—Discomfort—Dactinomycin—testicular cancer	0.0028	0.00482	CcSEcCtD
Amifostine—Hypersensitivity—Chlorambucil—testicular cancer	0.00277	0.00477	CcSEcCtD
Amifostine—Malaise—Ifosfamide—testicular cancer	0.00275	0.00473	CcSEcCtD
Amifostine—Hypotension—Bleomycin—testicular cancer	0.00272	0.00468	CcSEcCtD
Amifostine—Arrhythmia—Cisplatin—testicular cancer	0.0027	0.00464	CcSEcCtD
Amifostine—Pruritus—Chlorambucil—testicular cancer	0.00266	0.00458	CcSEcCtD
Amifostine—Convulsion—Ifosfamide—testicular cancer	0.00264	0.00455	CcSEcCtD
Amifostine—Hypertension—Ifosfamide—testicular cancer	0.00263	0.00453	CcSEcCtD
Amifostine—Erythema multiforme—Etoposide—testicular cancer	0.00262	0.0045	CcSEcCtD
Amifostine—Dyspnoea—Bleomycin—testicular cancer	0.0026	0.00447	CcSEcCtD
Amifostine—Chest pain—Ifosfamide—testicular cancer	0.0026	0.00447	CcSEcCtD
Amifostine—Flushing—Etoposide—testicular cancer	0.00257	0.00442	CcSEcCtD
Amifostine—Discomfort—Ifosfamide—testicular cancer	0.00257	0.00442	CcSEcCtD
Amifostine—Hypersensitivity—Vinblastine—testicular cancer	0.00254	0.00437	CcSEcCtD
Amifostine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00254	0.00437	CcSEcCtD
Amifostine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00249	0.00428	CcSEcCtD
Amifostine—Chills—Etoposide—testicular cancer	0.00248	0.00427	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00248	0.00426	CcSEcCtD
Amifostine—Ill-defined disorder—Cisplatin—testicular cancer	0.00244	0.0042	CcSEcCtD
Amifostine—Feeling abnormal—Bleomycin—testicular cancer	0.0024	0.00413	CcSEcCtD
Amifostine—Vomiting—Chlorambucil—testicular cancer	0.00239	0.00412	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00238	0.00409	CcSEcCtD
Amifostine—Malaise—Cisplatin—testicular cancer	0.00237	0.00408	CcSEcCtD
Amifostine—Hypotension—Ifosfamide—testicular cancer	0.00233	0.004	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00232	0.00399	CcSEcCtD
Amifostine—Urticaria—Bleomycin—testicular cancer	0.00231	0.00398	CcSEcCtD
Amifostine—Body temperature increased—Bleomycin—testicular cancer	0.0023	0.00396	CcSEcCtD
Amifostine—Dizziness—Vinblastine—testicular cancer	0.00228	0.00392	CcSEcCtD
Amifostine—Convulsion—Cisplatin—testicular cancer	0.00228	0.00392	CcSEcCtD
Amifostine—Feeling abnormal—Dactinomycin—testicular cancer	0.00224	0.00385	CcSEcCtD
Amifostine—Nausea—Chlorambucil—testicular cancer	0.00224	0.00385	CcSEcCtD
Amifostine—Ill-defined disorder—Etoposide—testicular cancer	0.00224	0.00385	CcSEcCtD
Amifostine—Dyspnoea—Ifosfamide—testicular cancer	0.00222	0.00382	CcSEcCtD
Amifostine—Somnolence—Ifosfamide—testicular cancer	0.00221	0.00381	CcSEcCtD
Amifostine—Discomfort—Cisplatin—testicular cancer	0.00221	0.00381	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.0022	0.00378	CcSEcCtD
Amifostine—Vomiting—Vinblastine—testicular cancer	0.00219	0.00377	CcSEcCtD
Amifostine—Malaise—Etoposide—testicular cancer	0.00217	0.00374	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00216	0.00371	CcSEcCtD
Amifostine—Body temperature increased—Dactinomycin—testicular cancer	0.00215	0.0037	CcSEcCtD
Amifostine—Anaphylactic shock—Cisplatin—testicular cancer	0.00215	0.00369	CcSEcCtD
Amifostine—Hypersensitivity—Bleomycin—testicular cancer	0.00215	0.00369	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00214	0.00369	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—testicular cancer	0.00213	0.00367	CcSEcCtD
Amifostine—Loss of consciousness—Etoposide—testicular cancer	0.00212	0.00364	CcSEcCtD
Amifostine—Tachycardia—Cisplatin—testicular cancer	0.00209	0.0036	CcSEcCtD
Amifostine—Convulsion—Etoposide—testicular cancer	0.00209	0.00359	CcSEcCtD
Amifostine—Hypertension—Etoposide—testicular cancer	0.00208	0.00358	CcSEcCtD
Amifostine—Pruritus—Bleomycin—testicular cancer	0.00206	0.00355	CcSEcCtD
Amifostine—Feeling abnormal—Ifosfamide—testicular cancer	0.00205	0.00353	CcSEcCtD
Amifostine—Chest pain—Etoposide—testicular cancer	0.00205	0.00353	CcSEcCtD
Amifostine—Nausea—Vinblastine—testicular cancer	0.00205	0.00353	CcSEcCtD
Amifostine—Discomfort—Etoposide—testicular cancer	0.00203	0.00349	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00202	0.00347	CcSEcCtD
Amifostine—Hypotension—Cisplatin—testicular cancer	0.00201	0.00345	CcSEcCtD
Amifostine—Hypersensitivity—Dactinomycin—testicular cancer	0.002	0.00344	CcSEcCtD
Amifostine—Urticaria—Ifosfamide—testicular cancer	0.00198	0.0034	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—testicular cancer	0.00197	0.0034	CcSEcCtD
Amifostine—Body temperature increased—Ifosfamide—testicular cancer	0.00197	0.00339	CcSEcCtD
Amifostine—Anaphylactic shock—Etoposide—testicular cancer	0.00197	0.00338	CcSEcCtD
Amifostine—Tachycardia—Etoposide—testicular cancer	0.00192	0.0033	CcSEcCtD
Amifostine—Dyspnoea—Cisplatin—testicular cancer	0.00191	0.00329	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00187	0.00322	CcSEcCtD
Amifostine—Vomiting—Bleomycin—testicular cancer	0.00185	0.00319	CcSEcCtD
Amifostine—Hypotension—Etoposide—testicular cancer	0.00184	0.00316	CcSEcCtD
Amifostine—Rash—Bleomycin—testicular cancer	0.00184	0.00316	CcSEcCtD
Amifostine—Dermatitis—Bleomycin—testicular cancer	0.00184	0.00316	CcSEcCtD
Amifostine—Hypersensitivity—Ifosfamide—testicular cancer	0.00183	0.00316	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00183	0.00315	CcSEcCtD
Amifostine—Renal failure—Methotrexate—testicular cancer	0.00182	0.00312	CcSEcCtD
Amifostine—Feeling abnormal—Cisplatin—testicular cancer	0.00177	0.00304	CcSEcCtD
Amifostine—Pruritus—Ifosfamide—testicular cancer	0.00176	0.00303	CcSEcCtD
Amifostine—Dyspnoea—Etoposide—testicular cancer	0.00175	0.00302	CcSEcCtD
Amifostine—Somnolence—Etoposide—testicular cancer	0.00175	0.00301	CcSEcCtD
Amifostine—Nausea—Bleomycin—testicular cancer	0.00173	0.00298	CcSEcCtD
Amifostine—Vomiting—Dactinomycin—testicular cancer	0.00173	0.00297	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00171	0.00295	CcSEcCtD
Amifostine—Rash—Dactinomycin—testicular cancer	0.00171	0.00295	CcSEcCtD
Amifostine—Renal failure—Epirubicin—testicular cancer	0.0017	0.00292	CcSEcCtD
Amifostine—Body temperature increased—Cisplatin—testicular cancer	0.0017	0.00292	CcSEcCtD
Amifostine—Dizziness—Ifosfamide—testicular cancer	0.00165	0.00283	CcSEcCtD
Amifostine—Feeling abnormal—Etoposide—testicular cancer	0.00162	0.00279	CcSEcCtD
Amifostine—Nausea—Dactinomycin—testicular cancer	0.00161	0.00278	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00159	0.00273	CcSEcCtD
Amifostine—Vomiting—Ifosfamide—testicular cancer	0.00158	0.00272	CcSEcCtD
Amifostine—Hypersensitivity—Cisplatin—testicular cancer	0.00158	0.00272	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—testicular cancer	0.00158	0.00272	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—testicular cancer	0.00157	0.0027	CcSEcCtD
Amifostine—Rash—Ifosfamide—testicular cancer	0.00157	0.0027	CcSEcCtD
Amifostine—Dermatitis—Ifosfamide—testicular cancer	0.00157	0.0027	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—testicular cancer	0.00157	0.0027	CcSEcCtD
Amifostine—Urticaria—Etoposide—testicular cancer	0.00156	0.00269	CcSEcCtD
Amifostine—Body temperature increased—Etoposide—testicular cancer	0.00155	0.00267	CcSEcCtD
Amifostine—Chills—Methotrexate—testicular cancer	0.00149	0.00256	CcSEcCtD
Amifostine—Nausea—Ifosfamide—testicular cancer	0.00148	0.00254	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—testicular cancer	0.00147	0.00252	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—testicular cancer	0.00146	0.00251	CcSEcCtD
Amifostine—Hypersensitivity—Etoposide—testicular cancer	0.00145	0.00249	CcSEcCtD
Amifostine—Flushing—Epirubicin—testicular cancer	0.00144	0.00248	CcSEcCtD
Amifostine—Chills—Epirubicin—testicular cancer	0.00139	0.0024	CcSEcCtD
Amifostine—Pruritus—Etoposide—testicular cancer	0.00139	0.00239	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—testicular cancer	0.00139	0.00238	CcSEcCtD
Amifostine—Vomiting—Cisplatin—testicular cancer	0.00136	0.00235	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—testicular cancer	0.00136	0.00234	CcSEcCtD
Amifostine—Rash—Cisplatin—testicular cancer	0.00135	0.00233	CcSEcCtD
Amifostine—Dermatitis—Cisplatin—testicular cancer	0.00135	0.00233	CcSEcCtD
Amifostine—Ill-defined disorder—Methotrexate—testicular cancer	0.00134	0.0023	CcSEcCtD
Amifostine—Flushing—Doxorubicin—testicular cancer	0.00133	0.00229	CcSEcCtD
Amifostine—Malaise—Methotrexate—testicular cancer	0.0013	0.00224	CcSEcCtD
Amifostine—Dizziness—Etoposide—testicular cancer	0.0013	0.00224	CcSEcCtD
Amifostine—Chills—Doxorubicin—testicular cancer	0.00129	0.00222	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—testicular cancer	0.00128	0.00221	CcSEcCtD
Amifostine—Nausea—Cisplatin—testicular cancer	0.00127	0.00219	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—testicular cancer	0.00125	0.00216	CcSEcCtD
Amifostine—Convulsion—Methotrexate—testicular cancer	0.00125	0.00215	CcSEcCtD
Amifostine—Vomiting—Etoposide—testicular cancer	0.00125	0.00215	CcSEcCtD
Amifostine—Rash—Etoposide—testicular cancer	0.00124	0.00213	CcSEcCtD
Amifostine—Dermatitis—Etoposide—testicular cancer	0.00124	0.00213	CcSEcCtD
Amifostine—Chest pain—Methotrexate—testicular cancer	0.00123	0.00211	CcSEcCtD
Amifostine—Malaise—Epirubicin—testicular cancer	0.00122	0.0021	CcSEcCtD
Amifostine—Discomfort—Methotrexate—testicular cancer	0.00121	0.00209	CcSEcCtD
Amifostine—Syncope—Epirubicin—testicular cancer	0.00121	0.00208	CcSEcCtD
Amifostine—Loss of consciousness—Epirubicin—testicular cancer	0.00119	0.00204	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—testicular cancer	0.00118	0.00203	CcSEcCtD
Amifostine—Convulsion—Epirubicin—testicular cancer	0.00117	0.00201	CcSEcCtD
Amifostine—Nausea—Etoposide—testicular cancer	0.00117	0.00201	CcSEcCtD
Amifostine—Hypertension—Epirubicin—testicular cancer	0.00117	0.00201	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—testicular cancer	0.00116	0.002	CcSEcCtD
Amifostine—Chest pain—Epirubicin—testicular cancer	0.00115	0.00198	CcSEcCtD
Amifostine—Discomfort—Epirubicin—testicular cancer	0.00114	0.00195	CcSEcCtD
Amifostine—Malaise—Doxorubicin—testicular cancer	0.00113	0.00194	CcSEcCtD
Amifostine—Syncope—Doxorubicin—testicular cancer	0.00112	0.00193	CcSEcCtD
Amifostine—Anaphylactic shock—Epirubicin—testicular cancer	0.0011	0.0019	CcSEcCtD
Amifostine—Hypotension—Methotrexate—testicular cancer	0.0011	0.00189	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—testicular cancer	0.0011	0.00189	CcSEcCtD
Amifostine—Shock—Epirubicin—testicular cancer	0.00108	0.00187	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—testicular cancer	0.00108	0.00186	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—testicular cancer	0.00108	0.00186	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—testicular cancer	0.00108	0.00185	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—testicular cancer	0.00106	0.00183	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—testicular cancer	0.00105	0.00181	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—testicular cancer	0.00105	0.00181	CcSEcCtD
Amifostine—Somnolence—Methotrexate—testicular cancer	0.00105	0.0018	CcSEcCtD
Amifostine—Hypotension—Epirubicin—testicular cancer	0.00103	0.00177	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00102	0.00175	CcSEcCtD
Amifostine—Shock—Doxorubicin—testicular cancer	0.001	0.00173	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—testicular cancer	0.000995	0.00171	CcSEcCtD
Amifostine—Dyspnoea—Epirubicin—testicular cancer	0.000983	0.00169	CcSEcCtD
Amifostine—Somnolence—Epirubicin—testicular cancer	0.00098	0.00169	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—testicular cancer	0.000971	0.00167	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—testicular cancer	0.000953	0.00164	CcSEcCtD
Amifostine—Urticaria—Methotrexate—testicular cancer	0.000936	0.00161	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—testicular cancer	0.000931	0.0016	CcSEcCtD
Amifostine—Dyspnoea—Doxorubicin—testicular cancer	0.000909	0.00156	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—testicular cancer	0.000908	0.00156	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—testicular cancer	0.000907	0.00156	CcSEcCtD
Amifostine—Urticaria—Epirubicin—testicular cancer	0.000876	0.00151	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—testicular cancer	0.000871	0.0015	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—testicular cancer	0.000868	0.00149	CcSEcCtD
Amifostine—Feeling abnormal—Doxorubicin—testicular cancer	0.00084	0.00145	CcSEcCtD
Amifostine—Pruritus—Methotrexate—testicular cancer	0.000833	0.00143	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—testicular cancer	0.000812	0.0014	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—testicular cancer	0.00081	0.00139	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—testicular cancer	0.000806	0.00139	CcSEcCtD
Amifostine—Pruritus—Epirubicin—testicular cancer	0.00078	0.00134	CcSEcCtD
Amifostine—Dizziness—Methotrexate—testicular cancer	0.000779	0.00134	CcSEcCtD
Amifostine—Hypersensitivity—Doxorubicin—testicular cancer	0.000751	0.00129	CcSEcCtD
Amifostine—Vomiting—Methotrexate—testicular cancer	0.000749	0.00129	CcSEcCtD
Amifostine—Rash—Methotrexate—testicular cancer	0.000743	0.00128	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—testicular cancer	0.000742	0.00128	CcSEcCtD
Amifostine—Dizziness—Epirubicin—testicular cancer	0.000729	0.00125	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—testicular cancer	0.000722	0.00124	CcSEcCtD
Amifostine—Vomiting—Epirubicin—testicular cancer	0.000701	0.00121	CcSEcCtD
Amifostine—Nausea—Methotrexate—testicular cancer	0.0007	0.0012	CcSEcCtD
Amifostine—Rash—Epirubicin—testicular cancer	0.000695	0.0012	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—testicular cancer	0.000694	0.00119	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—testicular cancer	0.000674	0.00116	CcSEcCtD
Amifostine—Nausea—Epirubicin—testicular cancer	0.000655	0.00113	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—testicular cancer	0.000648	0.00112	CcSEcCtD
Amifostine—Rash—Doxorubicin—testicular cancer	0.000643	0.00111	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—testicular cancer	0.000642	0.00111	CcSEcCtD
Amifostine—Nausea—Doxorubicin—testicular cancer	0.000606	0.00104	CcSEcCtD
